These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
258 related items for PubMed ID: 18817910
1. Prospective prenatal serum screening for Down syndrome in Venezuela. Alvarez-Nava F, Soto M, Morales-Machín A, Rojas A, Urdaneta K, Cañizález J. Int J Gynaecol Obstet; 2008 Dec; 103(3):241-5. PubMed ID: 18817910 [Abstract] [Full Text] [Related]
2. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study. Kellner LH, Weiner Z, Weiss RR, Neuer M, Martin GM, Mueenuddin M, Bombard A. Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343 [Abstract] [Full Text] [Related]
3. Contingent triple-screening for Down syndrome in the second trimester: a feasibility study in Mainland Chinese population. Xie Z, Lu S, Li H. Prenat Diagn; 2010 Jan; 30(1):74-6. PubMed ID: 19967750 [Abstract] [Full Text] [Related]
4. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome]. Liao S, Wang Y, Ye G. Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764 [Abstract] [Full Text] [Related]
7. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP, Elias S, Shulman LP, Andersen RN, Morgan CD, Simpson JL. Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [Abstract] [Full Text] [Related]
10. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy]. Yu DY, Fu P, Zhang ZH, Wang F, Han MY, Ren HY, Zhao W, Zhang K, Li S, Jiang N. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235 [Abstract] [Full Text] [Related]
15. [Prenatal maternal blood screening for the detection of fetal chromosomal abnormalities: clinical importance of the rate of false positives]. Alvarez-Nava F, Soto M, Padrón T, Morales A, Villalobos D, Rojas de Atencio A, Prieto M, Martínez MC. Invest Clin; 2003 Sep; 44(3):195-207. PubMed ID: 14552058 [Abstract] [Full Text] [Related]
19. Screening of maternal serum for fetal Down's syndrome in the first trimester. Haddow JE, Palomaki GE, Knight GJ, Williams J, Miller WA, Johnson A. N Engl J Med; 1998 Apr 02; 338(14):955-61. PubMed ID: 9521983 [Abstract] [Full Text] [Related]
20. First-trimester or second-trimester screening, or both, for Down's syndrome. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME, First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. N Engl J Med; 2005 Nov 10; 353(19):2001-11. PubMed ID: 16282175 [Abstract] [Full Text] [Related] Page: [Next] [New Search]